SEC ownership of Biofrontera Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001858685.

Comparable stake leader

Balaton Aktiengesellschaft Deutsche

Disclosed value leader

Rosalind Advisors, Inc.

Comparable rows

17/34

Latest evidence

31 Mar 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
17 of 34
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Balaton Aktiengesellschaft Deutsche
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
31 Mar 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001858685
Issuer location
Woburn, MA

Ownership snapshot

Top shareholders of Biofrontera Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Balaton Aktiengesellschaf...
Disclosed value leader
Rosalind Advisors, Inc.
Comparable rows
17/34
Latest evidence
31 Mar 2026
13D/G 3/4/5 13F Lead comparable stake: 20% 17 rows are not safely comparable across share classes. 13D/G row: Balaton Aktiengesellschaft Deutsche Showing 1-8 of 34 holder rows.

Quick read

Balaton Aktiengesellschaft Deutsche leads the comparable SEC ownership view at 20%.

17 of 34 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Balaton Aktiengesellschaft Deutsche's linked filing trail.
Comparable ownership Top 5
Balaton Aktiengesellschaft Deutsche 20%
Rosalind Advisors, Inc. 9.9%
Orin Hirschman 7.9%
Laurence W. Lytton 3.5%
Unternehmensberatung Aktiengesell... 0.28%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 34 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Balaton Aktiengesellschaft Deutsche
13D/G 3/4/5
Deutsche Balaton Aktiengesellschaft · 10%+ Owner
20%
$2,194,918
2,552,230 shares
+$1,800,278 16 Sep 2025
Rosalind Advisors, Inc.
13D/G 13F
Company
9.9%
$11,817,810
16,188,781 shares
-$429,412 31 Dec 2025
Orin Hirschman
13D/G
7.9%
$741,320
915,210 shares
+$24,824 31 Dec 2025
Laurence W. Lytton
13D/G
LYTTON LAURENCE W
3.5%
$254,561
306,700 shares
$0 31 Mar 2025
Unternehmensberatung Aktiengesellschaft Delphi
3/4/5
10%+ Owner
0.28%
$394,640
458,884 shares
16 Sep 2025
Vv Beteiligungen Aktiengesellschaft
3/4/5
10%+ Owner
0.28%
$394,640
458,884 shares
16 Sep 2025
Wilhelm Konrad Thomas Zours
3/4/5
10%+ Owner
0.28%
$394,640
458,884 shares
16 Sep 2025
Maria del Pilar de la Huerta Martinez
3/4/5
Director, 10%+ Owner
0.24%
$344,000
400,000 shares
16 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 27 Jun 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-18 of 18 reporting-owner rows connected to Biofrontera Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
18
Largest Forms 3/4/5 holder
Vv Beteiligungen Aktiengesellschaft
Net 12M change
$0
Latest report
04 Mar 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Vv Beteiligungen Aktiengesellschaft 10%+ Owner $394,640 Mixed 16 Sep 2025
Unternehmensberatung Aktiengesellschaft Delphi 10%+ Owner $394,640 Mixed 16 Sep 2025
Wilhelm Konrad Thomas Zours 10%+ Owner $394,640 Mixed 16 Sep 2025
Balaton Aktiengesellschaft Deutsche 10%+ Owner $394,640 Mixed 16 Sep 2025
Maria del Pilar de la Huerta Martinez Director, 10%+ Owner $344,000 Mixed 16 Sep 2025
Biofrontera AG Director, 10%+ Owner $260,000 Mixed 16 Sep 2025
Hermann Luebbert CEO & Chairman, Director $235,070 Mixed 04 Mar 2026
Eugene Frederick Leffler III Chief Financial Officer $141,750 Mixed 04 Mar 2026
Heikki Lanckriet Director Mixed 04 Mar 2026
Loretta M. Wedge Director Mixed 18 May 2022
George Patrick Jones Chief Commercial Officer Mixed 04 Mar 2026
John J. Borer III Director Mixed 04 Mar 2026
Kevin D. Weber Director Mixed 04 Mar 2026
Beth J. Hoffman Director Mixed 04 Mar 2026
Christian Alexander Ansgar Link 10%+ Owner Mixed 16 Sep 2025
Hansjoerg Plaggemars 10%+ Owner Mixed 16 Sep 2025
Erica L. Monaco Chief Executive Officer Mixed 18 May 2023
Erica F. Gates Senior Director Finance Mixed 14 Nov 2022

Recent insider transactions for Biofrontera Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Hermann Luebbert BFRI Common Stock Options Exercise 90% 137,500 290,211 05 Mar 2026 Direct
Hermann Luebbert BFRI Restricted Stock Units Options Exercise -100% -137,500 0 05 Mar 2026 Direct
Eugene Frederick Leffler III BFRI Common Stock Options Exercise 100% 87,500 175,000 05 Mar 2026 Direct
Eugene Frederick Leffler III BFRI Restricted Stock Units Options Exercise -100% -87,500 0 05 Mar 2026 Direct
Kevin D. Weber BFRI Employee stock option (right to buy) Award 20,000 20,000 04 Mar 2026 Direct
Hermann Luebbert BFRI Employee stock option (right to buy) Award 125,000 125,000 04 Mar 2026 Direct
Hermann Luebbert BFRI Restricted Stock Units Award 125,000 125,000 04 Mar 2026 Direct
Eugene Frederick Leffler III BFRI Employee stock option (right to buy) Award 62,500 62,500 04 Mar 2026 Direct
Eugene Frederick Leffler III BFRI Restricted Stock Units Award 62,500 62,500 04 Mar 2026 Direct
Heikki Lanckriet BFRI Employee stock option (right to buy) Award 20,000 20,000 04 Mar 2026 Direct
Beth J. Hoffman BFRI Employee stock option (right to buy) Award 20,000 20,000 04 Mar 2026 Direct
George Patrick Jones BFRI Employee stock option (right to buy) Award 50,000 50,000 04 Mar 2026 Direct
George Patrick Jones BFRI Restricted Stock Units Award 50,000 50,000 04 Mar 2026 Direct
John J. Borer III BFRI Employee stock option (right to buy) Award 20,000 20,000 04 Mar 2026 Direct
Biofrontera AG BFRI Series D Convertible Preferred Stock Purchase 3,019 3,019 16 Sep 2025 Direct
George Patrick Jones BFRI Employee stock option (right to buy) Award 100,000 100,000 15 Sep 2025 Direct
Hermann Luebbert BFRI Common Stock Options Exercise 904% 137,500 152,711 10 Sep 2025 Direct
Hermann Luebbert BFRI Restricted Stock Units Options Exercise -50% -137,500 137,500 10 Sep 2025 Direct
Eugene Frederick Leffler III BFRI Common Stock Options Exercise 87,500 87,500 10 Sep 2025 Direct
Eugene Frederick Leffler III BFRI Restricted Stock Units Options Exercise -50% -87,500 87,500 10 Sep 2025 Direct
Kevin D. Weber BFRI Employee stock option (right to buy) Award 20,000 20,000 22 Jul 2025 Direct
Hermann Luebbert BFRI Employee stock option (right to buy) Award 125,000 125,000 22 Jul 2025 Direct
Hermann Luebbert BFRI Restricted Stock Units Award 125,000 125,000 22 Jul 2025 Direct
Eugene Frederick Leffler III BFRI Employee stock option (right to buy) Award 62,500 62,500 22 Jul 2025 Direct
Eugene Frederick Leffler III BFRI Restricted Stock Units Award 62,500 62,500 22 Jul 2025 Direct
Heikki Lanckriet BFRI Employee stock option (right to buy) Award 20,000 20,000 22 Jul 2025 Direct
Beth J. Hoffman BFRI Employee stock option (right to buy) Award 20,000 20,000 22 Jul 2025 Direct
John J. Borer III BFRI Employee stock option (right to buy) Award 20,000 20,000 22 Jul 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .